KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $10.5 billion.

  • Merck's Operating Expenses fell 1620.12% to $10.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 billion, marking a year-over-year decrease of 1422.74%. This contributed to the annual value of $44.2 billion for FY2024, which is 2403.39% down from last year.
  • Merck's Operating Expenses amounted to $10.5 billion in Q3 2025, which was down 1620.12% from $10.8 billion recorded in Q2 2025.
  • Merck's Operating Expenses' 5-year high stood at $20.4 billion during Q2 2023, with a 5-year trough of $7.6 billion in Q1 2021.
  • Over the past 5 years, Merck's median Operating Expenses value was $10.3 billion (recorded in 2023), while the average stood at $11.1 billion.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 10156.34% in 2023, then plummeted by 5038.78% in 2024.
  • Merck's Operating Expenses (Quarter) stood at $9.6 billion in 2021, then rose by 7.33% to $10.3 billion in 2022, then surged by 61.64% to $16.7 billion in 2023, then crashed by 31.31% to $11.5 billion in 2024, then decreased by 8.06% to $10.5 billion in 2025.
  • Its last three reported values are $10.5 billion in Q3 2025, $10.8 billion for Q2 2025, and $9.6 billion during Q1 2025.